You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Merck
Express Scripts
Mallinckrodt
McKinsey

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

DOVONEX Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Dovonex, and when can generic versions of Dovonex launch?

Dovonex is a drug marketed by Leo Pharma As and Leo Pharm and is included in three NDAs.

The generic ingredient in DOVONEX is calcipotriene. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the calcipotriene profile page.

US ANDA Litigation and Generic Entry Outlook for Dovonex

A generic version of DOVONEX was approved as calcipotriene by FOUGERA PHARMS on May 6th, 2008.

  Start Trial

Drug patent expirations by year for DOVONEX
Drug Prices for DOVONEX

See drug prices for DOVONEX

Recent Clinical Trials for DOVONEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Guangdong Provincial Hospital of Traditional Chinese MedicineN/A
Northwestern UniversityN/A
Washington University School of MedicinePhase 0

See all DOVONEX clinical trials

Pharmacology for DOVONEX
Paragraph IV (Patent) Challenges for DOVONEX
Tradename Dosage Ingredient NDA Submissiondate
DOVONEX CREAM;TOPICAL calcipotriene 020554 2009-12-02
DOVONEX SOLUTION;TOPICAL calcipotriene 020611 2006-05-19

US Patents and Regulatory Information for DOVONEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leo Pharma As DOVONEX calcipotriene CREAM;TOPICAL 020554-001 Jul 22, 1996 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Leo Pharma As DOVONEX calcipotriene OINTMENT;TOPICAL 020273-001 Dec 29, 1993 DISCN Yes No   Start Trial   Start Trial   Start Trial
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DOVONEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997   Start Trial   Start Trial
Leo Pharma As DOVONEX calcipotriene CREAM;TOPICAL 020554-001 Jul 22, 1996   Start Trial   Start Trial
Leo Pharma As DOVONEX calcipotriene CREAM;TOPICAL 020554-001 Jul 22, 1996   Start Trial   Start Trial
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997   Start Trial   Start Trial
Leo Pharma As DOVONEX calcipotriene OINTMENT;TOPICAL 020273-001 Dec 29, 1993   Start Trial   Start Trial
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Express Scripts
Dow
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.